These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 146821)

  • 1. On the action of delta 9-tetrahydrocannabinol as an inhibitor of sodium- and potassium-dependent adenosine triphosphatase.
    Toro-Goyco E; Rodréguez MB; Preston AM
    Mol Pharmacol; 1978 Jan; 14(1):130-7. PubMed ID: 146821
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cannabis extract and delta-9-tetrahydrocannabinol on brain adenosine triphosphatase activity.
    Poddar MK; Ghosh JJ
    Indian J Biochem Biophys; 1976 Sep; 13(3):267-72. PubMed ID: 137878
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory sites on sodium- and potassium-activated adenosine triphosphatase for chlorpromazine free radical and ouabain.
    Akera T; Brody TM
    Mol Pharmacol; 1970 Sep; 6(5):557-66. PubMed ID: 4248267
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibiton of sodium- and potassium-dependent adenosine triphosphatase by serotonin.
    García-Castiñeiras S; White JI; Toro-Goyco E
    Mol Pharmacol; 1977 Jan; 13(1):181-4. PubMed ID: 138079
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in activated magnesium and sodium plus potassium adenosine triphosphatase and the krebs cycle in hemorrhagic shock.
    Baue AE; Wurth MA; Sayeed MM
    Surg Forum; 1970; 21():8-10. PubMed ID: 4255230
    [No Abstract]   [Full Text] [Related]  

  • 6. Lithium and rubidium interactions with sodium- and potassium-dependent adenosine triphosphatase: a molecular basis for the pharmacological actions of these ions.
    Tobin T; Akera T; Han CS; Brody TM
    Mol Pharmacol; 1974 May; 10(3):501-8. PubMed ID: 4277565
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of oligomycin inhibition of sodium- and potassium-activated adenosine triphosphatase from beef brain.
    Inturrisi CE; Titus E
    Mol Pharmacol; 1968 Nov; 4(6):591-9. PubMed ID: 4235717
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
    Tobin T; Akera T; Ku D; Lu MC
    Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by digoxin covalently bound to Sepharose.
    Okarma TB; Tramell P; Kalman SM
    Mol Pharmacol; 1972 Jul; 8(4):476-80. PubMed ID: 4262306
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction between chlorpromazine free radical and microsomal sodium- and potassium-activated adenosine triphosphatase from rat brain.
    Akera T; Brody TM
    Mol Pharmacol; 1969 Nov; 5(6):605-14. PubMed ID: 4244695
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adenosinetriphosphatase activity of nuclear envelopes and from the cells of rat liver, Zaigdel hepatoma of rats and Ehrlich ascites tumour of mice].
    Delektorskaia LN; Perevoshchikov KA
    Biokhimiia; 1969; 34(1):199-203. PubMed ID: 4308300
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
    Palatini P
    Mol Pharmacol; 1977 Mar; 13(2):216-23. PubMed ID: 192990
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium ion and sodium- and potassium-dependent adenosine triphosphatase: its mechanism of inhibition and identification of the E 1 -P intermediate.
    Tobin T; Akera T; Baskin SI; Brody TM
    Mol Pharmacol; 1973 May; 9(3):336-49. PubMed ID: 4267957
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of brain sodium- and potassium-stimulated adenosine triphosphatase activity by chlorpromazine free radical.
    Akera T; Brody TM
    Mol Pharmacol; 1968 Nov; 4(6):600-12. PubMed ID: 4235718
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of delta-9 tetrahydrocannabinol on rat intestinal ATPases.
    Sengupta D; Chakravorty I; Datta SC; Ghosh JJ
    Indian J Biochem Biophys; 1977 Mar; 14(1):93-4. PubMed ID: 144701
    [No Abstract]   [Full Text] [Related]  

  • 16. Ouabain binding to sodium- and potassium-dependent adenosine triphosphatase: inhibition by the , -methylene analogue of adenosine triphosphate.
    Tobin T; Akera T; Hogg RE; Brody TM
    Mol Pharmacol; 1973 Mar; 9(2):278-81. PubMed ID: 4268124
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotics as tools for metabolic studies. XVIII. Inhibition of sodium- and potassium-dependent adenosine triphosphatase.
    Susa JB; Lardy HA
    Mol Pharmacol; 1975 Mar; 11(2):166-73. PubMed ID: 123632
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of sodium, potassium, and magnesium activated ATPases by acetaldehyde and "biogenic" aldehydes.
    Tabakoff B
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):621-4. PubMed ID: 4274797
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo effect of LSD, morphine, ethanol and delta9-tetrahydrocannabinol on mouse brain adenosine triphosphatase activity.
    Jain ML; Curtis BM; Bakutis EV
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):229-32. PubMed ID: 4272745
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model.
    Wilson WE; Sivitz WI; Hanna LT
    Mol Pharmacol; 1970 Sep; 6(5):449-59. PubMed ID: 4248266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.